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Abstract Transferrin hepato-specific gene enhancer, associated 
with the liver-enriched HNF-3v~ transcriptional factor and ubiqui- 
tous proteins, is a complex molecular edifce maintained through 
DNA-protein and protein-protein interactions. As a first step to 
understand the mechanisms responsible for its organization and 
activity, we have analyzed the interaction of the DNA binding 
domain of HNF-3c~ (HDBD) with a specific DNA segment pres- 
ent in the transferrin enhancer by different biophysical tech- 
niques. The kinetic constants of this interaction were measured 
using surface plasmon resonance. The HDBD-DNA interaction 
was also characterized by circular dichroism and fluorescence 
spectroscopy. HDBD binds to its specific DNA site with high 
affinity (K~ 10 -s M). The affinity is reduced after sequence 
modification of the target DNA. Size exclusion chromatography 
and binding stoichiometry determined by fluorescence measure- 
ments indicate that the protein is present in a monomeric form 
before and after interaction with the DNA. The secondary struc- 
ture of the protein was not significantly altered upon binding to 
specific DNA. By contrast, a structural change of DNA by inter- 
action with HDBD seems to occur. 
Key words'. Transferrin enhancer; DNA-protein interaction; 
Transcription factor; HNF-3//brk head DNA binding domain 
1. Introduction 
Hepatocyte specific gene expression is controlled in part by 
nuclear proteins whose concentrations are particularly en- 
riched in liver. Among these, we found the hepatocyte nuclear 
factor 3 group of proteins, composed of HNF-3c~, HNF-3fl and 
HNF-3), [1 3]. These proteins belong to a rapidly growing 
family, the HNF-31Jbrk head (fkh) transcription factors, that 
share a 110 amino acids region responsible for their interaction 
with DNA. 
The structure of the binary complex between the HNF-37 
DNA binding domain and its DNA specific target site present 
in the promoter egion of the transthyretin gene [3] has been 
solved by X-ray crystallography at 0.25 nm resolution [4]. The 
fork head domain was recognized as a variant of the helix-turn- 
helix (HTH) motif, containing two loops on the C-terminal side 
of the HTH. Direct base contacts are made by an s-helix 
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intruding into the major groove of DNA and additional back- 
bone contacts are provided by the loops. This variant of the 
HTH, with loops or wings that project over DNA, has been 
called ~winged helix' domain [5]. In addition, after analysis of 
the binding properties of a series of chimaeric fkh DNA-bind- 
ing domain fusion proteins, other authors have proposed that 
a 20-amino acid sequence adjacent to the HNF-3 recognition 
s-helix influences its DNA-binding properties [6]. 
Recent studies have demonstrated that different fkh proteins 
bind to distinct DNA sites and that the specificity of protein 
recognition is dependent on subtle nucleotide alterations in the 
site [6]. It was also determined that the binding sites lbr four 
of the seven detected human fkh proteins (FREAC) share a 
core sequence, but differ in the positions flanking the core [7]. 
These flanking sequences appear to be more important in giv- 
ing each protein its specificity. In this context, it is important 
to underline that the oligonucleotide used t\~r the cocrystallisa- 
tion with HNF-3y did not extend beyond the 3' border of the 
HNF-3y binding core [3,4]. In addition, the two last base pairs 
of the oligonucleotide, which correspond to the two last posi- 
tions of the HNF-3y DNA recognition core, are diff,erent from 
those present in the binding site in the transthyrelin promoter 
[3,4]. All these considerations clearly indicate that more work 
with different members of the protein family is required to 
understand the exact nature of the fkh protein DNA com- 
plexes and how these proteins can specilically regulate their 
target genes. 
By studying transferrin gene expression as a model for liver- 
specific gene expression [8], we have previously demonstrated 
the existence of a transferrin gene enhancer, located between 
nucleotides -3600 to -3300 [9]. This enhancer is composed of 
two functional domains (A and B), containing five cnhansons 
named Ia, Ib, II, III and IV [10]. Characterization of the A 
domain, composed of enhanson Ia, and purification of liver 
proteins that interact with it, have shown that the detainer 
5'-TGTTTGCTTT-3' is essential for the enhancer activity and 
that HNF-37 specifically interacts with this DNA sequence 
[11]. Our restllts indicate that the Tf enhancer, associated with 
liver-enriched and ubiquitous proteins, constitutes a particular 
molecular edifice maintained through DNA protein and pro- 
tein-protein interactions [10]. To further understand the rolc 
of HNF-30t in the activity of this enhancer, we decided to study, 
as a first step, the interaction between the DNA binding do- 
main of HNF-3~ (HDBD) and its la specific target site. This 
interaction has been characterized by using surtace plasmon 
resonance (BlAcore system, Pharmacia Biosensor), circular di- 
chroism (CD) and fluorescence spectroscopies. 
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2. Materials and methods 
2.1. Materials 
All chemicals were of reagent grade. 
Buffer employed was: 10 mM Tris-Cl pH 8.05, 5 mM MgC12, 1 mM 
EDTA, 0.2 M NaCI, 0.05% Tween 20 (TEMNT). 
Nucleotide sequences of oligonucleotides u ed in this work are as 
follows: 
Ia, 5' GCTCTTTGTTTGCTTTGCTTCTGTGTCAAC 3' [11]; 
m2, 5' GCTCTTatTTTGCTTTGCTTCTGTGTCAAC 3' [11]; 
CR, 5' CTGTGCTGGACTCCTTCCACTCGCGGGTCGTC 3' [12]. 
2.2. Purification of  the recombinant HNF-3o; DNA binding domain 
(HDBD) 
The pGEX-2T expression vector (Pharmacia) was modified to con- 
tain a XbaI site instead of the SmaI site in the cloning region, and used 
to express an HDBD N-terminal fusion protein with glutathione S- 
transferase (GST). The coding sequence of HDBD was PCR amplified 
from a cDNA coding for the entire sequence of HNF-3c~ using oligonu- 
cleotides containing Xba] sites in the 5' side of the sequence to promote 
insertion in the XbaI site of the modified vector. The construction was 
verified by sequencing and used to transform DH5~ bacteria. The cells 
were grown in LB medium to an absorbance of 0.5 at 600 nm, and were 
then induced with 0.3 mM isopropyl tbio-fl-D-galactoside for 4 h at 
37°C under good aeration in the presence of 100,ug/ml ampicillin. Cells 
were harvested by centrifugation at 6000 × g. The pellet from 1000 ml 
of culture was resuspended in 20 ml of phosphate buffered saline (PBS) 
with 5 mM phenylmethylsulphonyl fluoride (PMSF), 1 mM dithiothre- 
itol (DTT), 0.5 pg/ml leupeptin, 0.7 pg/ml pepstatin and 40 gtg/ml 
bestatin. The cells were disrupted by gentle sonication (4 cycles/20 s) 
on ice, triton X-100 was added to a final concentration of 10%, and the 
suspension centrifuged for 20 min at 15000 × g. The supernatant was 
incubated overnight at 4°C with 2 ml of glutathione-Sepharose (Phar- 
macia). The resin was washed with 15 volumes of PBS and finally with 
thrombin cleavage buffer (50 mM Tris-C1 pH 8, 150 mM NaCI and 2.5 
mM CaCI2). Thrombin was added (approximately 0.05% w/v) and 
incubation performed for 2 h at room temperature. The cleaved protein 
was washed out by addition of 50 mM Tris-C1 pH 8, 0.4 M NaCI, 5 mM 
MgCI2, 1 mM DTT, 10% glycerol and applied to a Heparin Sepharose 
column connected to a FPLC system (HiTrap 5 ml, Pharmacia) after 
dilution to 50 mM NaCI in the same buffer without NaC1. The column 
was submitted to a linear elution gradient from 50 mM to 1 M of NaC1, 
in 5 column volumes; the protein was eluted at 630 mM NaCI and 
purified fractions were concentrated by ultrafiltration with Centricon 
3 (Amicon) membranes. The concentration of protein was obtained by 
direct calculation of the absorbance at 280 nm, using the calculated 
molar extinction coefficient of 27760 cm-tM -~. 
2.3. Electrophoretic mobility shift assays ( EMSA ) 
The standard assay as well as the competition experiments were 
performed as previously described [11], except hat the reaction temper- 
ature was 25°C instead of 4°C. The non-biotinylated Ia, m2 and CR 
oligonucleotides were used at a concentration of 1 nM. The comple- 
mentary strands were annealed at equimolar concentration i TE by 
slowly cooling the hybrid to 25°C after heating at 90°C during 5 rain. 
The CR oligonucleotide is a consensus binding site of NF1 in the 
human transferrin promoter [12], used as a non-specific DNA binding 
site for HDBD. GST-HDBD protein was used at a concentration of 20 
nM. 
2.4. BIAcore based kinetic analysis 
BIAcore instrument and sensorchips SA5 were manufactured by 
Pharmacia Biosensor AB (Uppsala, Sweden). 
The Tf sequences ( ee above) were annealed on the surface of the 
sensorchip, by initially passing the upper biotinylated strand, followed 
by the lower non-biotinylated strand. Each strand was diluted in flow 
buffer and passed over the surface at a rate of 5 pl/min during 1-2 min 
at a concentration of 10/lg/ml (upper biotinylated strand) or 100/lg/ml 
(lower non biotinylated strand). The hybridization level was calculated 
to be almost 100%. 
The protein was diluted in the BIAcore flow buffer (TEMNT). Dif- 
ferent concentrations of HDBD (40 pl) were injected at a flow rate of 
5 ml/min, followed by at least 5 min wash out to measure dissociation 
rates. To regenerate the surface after each sample, 2 pl of 2 M NaC1 
were injected and proved sufficient o dissociate the DNA protein 
complex. 
The reaction between immobilized DNA and HDBD can be assumed 
to follow pseudo-first-order kinetics [13] described by the rate equation: 
dR/dt = kass C (Rm, X - R) - kdis~R, 
where dR/dt is the rate of DNA-protein complex formation in the 
surface, k,~s is the association rate constant, kd~ss i the dissociation rate 
constant, R is the amount of bound HDBD, Rm~ x is the maximum 
represor binding capacity of the surface, and C is the concenration of 
HDBD in solution. For each concentration fprotein used the k~ (slope 
of the dR/dt vs R plot) was obtained and then presented as a function 
of the protein concentration. The slope of this curve is the k~: 
- k~ = k,~ C + kji~ 
A B 
i 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 '8 '9 10 ~- 12 13 14 
Fig. 1. EMSA assays using purified GST-HDBD and HDBD proteins. (A) The fusion protein GST-HDBD was used in EMSA assays as described 
in section 2. In lanes 1 to 7 the labelled probe is Ia; in lanes 8 to 14 the labelled probe is CR. Competitions were performed with 5, 50 and 250 molar 
excess unlabelled Ia probe (lanes 2 to 4, respectively and 9 to 11, respectively) or unlabelled CR probe (lanes 5 to 7, respectively and 12 to 14, 
respectively). (B) Purified HDBD at 0, 10, 50, 100, 200 and 500 nM (lanes 1 to 6, respectively) was incubated with Ia labelled probe. Lane 7 is a 
control with m2 labelled probe and 500 nM HDBD. The free probe is indicated by an arrow. 
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The k~,~, and ka,,~ were also calculated by non-linear regression anal- 
ysis (see below, section 3.3). The software BIAevaluation 2.0 (Pharma- 
cia Biosensor) was used to perform these calculations. The Ka (equilib- 
rium dissociation constant) was obtained as the ratio kd,~/k~. 
2.5. Size exclusion chromatography 
To calculate the relative molecular weight of native HDBD in solu- 
tion a Superdex-75 column (Pharmacia) was used following manufac- 
turers recommendations. A 25 ¢*1 sample of a 1 mM solution of HDBD 
in buffer TEMNT was applied to a Superdex-75 column connected to 
a FPLC system (Pharmacia), at 1 ml/min. The elution of HDBD was 
detected at 280 nm and also by SDS-PAGE analysis of the fractions. 
A mixture of gel filtration molecular weight markers (BSA, 67 kDa; 
ovalbumin, 43 kDa; chymotrypsinogen, 25 kDa and RNAse A, 13.7 
kDa) was used to obtain a calibration curve under the same elution 
conditions or HDBD. 
2.6. Spectroscopic measurements 
CircuLar dichroism (CD) was measured in a J-710 spectropolarimeter 
{Jasco, Japan) at room temperature (22 + 2°C). The band width was 
2 nm and spectra were usually averaged over 4 scans in order to 
improve the signal to noise ratio. The samples were measured in a 0.1 
cm cell and in a low salt buffer (10 mM sodium phosphate pH 6.7 with 
1 mM MgCI 2) to avoid excessive absorbance. (Note that C1 ion ab- 
sorbs light below 200 rim.) In order to facilitate the comparison of 
spectra, the spectrum of free DNA was subtracted from the spectrum 
ot' the protein DNA complex. 
Fluorescence was measured in a FP-777 spectrofluorometer (Jasco, 
Japan). The measurements were performed at 20°C. The excitation 
wavelength was set at 295 nm with a bandwidth of 3 nm for selective 
excitation of tryptophan residues. The emission wavelength was usually 
set at 340 nm with bandwidth of 5 nm. Inner filter effect due to the 
additional absorption from DNA was minimized by the use of a 0.2 
cm x 1 cm cell. The pathlength of incident light was thus less than 0.2 
cm. The signal intensity was, however, corrected for inner filter effect 
and dilution of sample upon successive addition of DNA solution. The 
correction was made by using the change in intensity of free tryptophan 
fluorescence upon the addition of equivalent amount of DNA solution 
as a standard. The cuvette was treated by silicon (Serva) to avoid Ihe 
adsorption of protein to the wall. 
3, Results 
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Fig. 2. Binding response of HDBD to Ia wild type DNA. (at The curves 
used to calculate the values shown in Table 1 and 2 are presented. 
HDBD concentration used was 50, 100 and 200 nM {curves a, b and 
c. respectively}, the buffer employed was TEMNT. (b) Plot of k~ vs 
concentration of HDBD. This plot represents a rate equation lineariza- 
tion method to determine k~,~, as the slope of the lhted line (see 
section 2). 
3.1. Ohtention <!1 the recombinant DNA binding domain o[" 
HNF-3(~ 
The amino acid sequence o f  the recombinant  HDBD ob- 
tained in bacter ia f rom a pGEX-2T  expression vector corre-  
sponds  to amino acid residues 164 to 291 of  the entire HNF-3cz 
protein [1]. The purified polypept ide is homogeneous  in SDS- 
PAGE as a unique band at approx imate ly  16 kDa (data not  
shown),  match ing well with the deduced molecular  weight o f  
15284 Da, est imated f rom the cDNA sequence. This was con- 
f irmed by size exclusion chromatography  (see below, section 
3.4). 
3.2. Analysis (~/ the DNA binding properties of HDBD 
To assess the funct ional  activity o f  the recombinant  HDBD 
obtained,  we per formed electrophoret ic  mobi l i ty shift assays 
(EMSA)  with the GST-HDBD fusion protein,  using the la 
DNA wild type site o f  the T f  gene enhancer  or an unrelated 
DNA sequence, CR (see section 21. As showed in Fig. la, the 
l\~rmation of  a specific DNA protein complex was observed 
between the fusion protein and the la ol igonucleotide,  but not 
with the CR sequence (Fig. la, lanes I 7 and 8 14, respec- 
tively). Compet i t ion  exper iments showed that the unlabelled Ia 
sequence, but not  the unlabel led CR sequence, is able to com- 
pete for binding with the la probe inhibit ing the format ion of  
the complex.  These results showed that, like the whole native 
protein,  the GST-HDBD recombinant  protein specifically in- 
teracts with the T f  Ia DNA region. This is also the case for the 
purified recombinant  HDBD polypeptide. Indeed. HDBD in- 
teracts with the Ia probe in a protein concentrat ion dependent  
manner  {Fig. lb, lanes 1 6), but not with the mutated m2 Tf  
enhancer  sequence (Fig. lb, lane 71. 
3.3. BlAcore bas'ed kinetic analysis 
The kinetic constants  of  DNA protein interact ions were 
Table 1 
Kinetic parameters of the interaction between HDBD and la DNA sequence 
DNA Protein k .... 
conc. (M l"s ') 
la 50 nM 2.34 x 105 + 9.13 x 10 ~ 
la 100 nM 0.82 x 10 ~ + 5.30 x 103 
la 21)0 nM 0.37 x 105 _+ 1.55 x 10 ~ 
kdiss 
Is ~) 
2.13 x 10 ~ + 5.95 x 10 -6 
1.71 x 10 3 + 6.42 x 10 -{' 
1.98 × 10 ; + 4.62 × 10 ~, 
'QI 
(M) 
~i)191× lO~± o.65× li} ~' 
2.09 × 10 , + 1.22 x I(} '~ 
5.38 × l{} ~ + 2.98 × 10 ') 
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Fig. 3. One to one binding stoichiometry of HDBD to DNA. (a) Anal- 
ysis of HDBD by size exclusion chromatography. Elution profile of 
HDBD in a Superdex-75 column running in TEMNT buffer. The elu- 
tion position of molecular weight markers are shown in the bottom of 
the figure. (b) and (c) Fluorescence change of HDBD upon DNA 
binding. (b) HDBD (2/IM) emission spectra upon excitation at 295 nm, 
before (-) and after (- -) addition of equimolar DNA fragment span- 
ning the la Tf enhancer specific site. (c) An oligonucleotide containing 
30 base pairs spanning the Ia type Tf binding site for HDBD was 
successively added to the protein solution (2 ,uM) and the fluorescence 
measured. The variation of fluorescence signal is presented as a func- 
tion of DNA fragment over protein ratio. 
measured using real time changes in surface plasmon resonance 
with the BIAcore system. The description of the kinetic analysis 
has already been reported [13] (see also, section 2). The curves 
used to generate the rate constants of the HNF-3~ interaction 
with the Ia Tf enhancer sequence are shown in Fig. 2a. 
The curves shown in Fig. 2a were analyzed with the BIAeval- 
uation software with a non-linear regression analysis to obtain 
the kas and kdiss for each HDBD concentration, the values are 
presented in Table 1. The kd~ was calculated from the part of 
the curve between 400 and 1200 s, where the data follow a 1:1 
DNA-protein interaction model. The ka~  seems to be some- 
what dependent on protein concentration, and this phenomena 
reflects on the calculated Ka. This could be due to a secondary 
binding event with similar k~, to the specific interaction with 
the Ia site, but probably with different kd~ constant. To test this 
hypothesis the dissociation part of the curve was treated as 
resulting from two different binding events. The response be- 
tween 320 and 1200 s was evaluated, to eliminate the interfering 
injection pulse. These data were treated with the B1Aevaluation 
software using non-linear regression analysis and the two dif- 
ferent kdiss obtained (ka~ and ko2, Table 2) could represent the 
first rapid dissociation of the non-specific omplex and the 
second dissociation event, one order of magnitude lower, that 
from the specific complex. The kj~ of the specific interaction 
calculated using this model (kd2) is very similar, as expected, to 
the kd,~ calculated with the single site model applied to the 
region between 400 and 1200 s (Table 1). 
To luther verify the data the k,~., was calculated using a linear 
regression analysis of a derivative of the binding curve (see 
section 2). From the slope of the fitted line in the plot of k~ vs 
concentration of HDBD, an estimated ka~  value of 6.1 x 10 4 
was obtained (Fig. 2b). This is in good agreement with the ka~  
obtained from non-linear regression (Table 1). 
3.4. HDBD is in a monomeric figrm beJore and after interaction 
with DNA 
HDBD was analyzed by size exclusion chromatography in 
a Superdex-75 column. In comparison to standard globular 
protein markers we deduced a Kav corresponding to the calcu- 
lated molecular mass of the protein, that is 15 kDa (Fig. 3a). 
This experiment shows that HDBD is present as a monomer 
in solution, as found for a Drosophila jork head domain by 
equilibrium sedimentation experiments [14]. 
Fig. 3b shows fluorescence emission spectra of HDBD before 
and after addition of the Ia Tf enhancer DNA fragment. The 
spectra were corrected for inner filter effect (1.2%) due to in- 
crease of absorption upon addition of DNA. The fluorescence 
intensity decreases about 30% upon addition of DNA. The 
titration of the protein by DNA shows that the fluorescence 
decreases linearly with increasing DNA concentration, as ex- 
pected from the very high binding affinity between HDBD and 
Ia DNA determined above (Table 1). The fluorescence r aches 
a plateau at about one DNA fragment per protein molecule 
(Fig. 3c). This binding stoichiometry indicates that the protein, 
demonstrated to be present as a monomer in solution (see 
above), also binds to DNA in a monomeric form. In addition, 
these results clearly show that the protein fluorescence is 
quenched upon binding to DNA. Since this fluorescence 
change was observed upon selective xcitation of tryptophan 
residues, we can conclude that the environment of some or all 
of these residues is altered by DNA binding. 
3.5. Secondary structure of HDBD free or bound to DNA 
The CD spectrum of the recombinant HDBD protein (Fig. 
4a) shows distinct negative peaks at 225 and 210 nm and a 
positive peak at 190 nm, indicating the existence of a significant 
content in c~-helical structure (15). This CD spectrum is similar 
to that obtained with the DNA binding domain of a Drosophila 
.fork head protein [14]. Analysis of the secondary structure from 
the obtained HDBD spectrum shows that the content of ~-helix 
is 30% and that offl-sheet 25%. This estimation was made by 
Table 2 
HDBD-Ia DNA sequence interaction 
DNA Protein kdt ka2 
concentration (s ~) (s -~) 
la 50nM 1.35x 10 2_+ 6.0x 10 -4 0.87x 10 3 + 3.4× 10 6 
la 100 nM 0.50 x 10 2 _+ 1.3 x 10 4 0.53 x 10 -3 ~ 6.9 X 10 6 
la 200 nM 0.67 x 10 2 _+ 0.8 x 10 -4 0.92 x 10 3 + 3.4 x 10 6 
Calculation of ko~s using a two independent si es model. 
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Fig. 4. CD spectra of HDBD and la DNA before and after interaction. The concentration f protein or DNA in each case was 10/IM. (a) CD spectra 
of a Ia oligonucleotide (dashed line) is shown along with that of free HDBD (solid line). (b) CD spectra of HDBD with (dashed line) and without 
la oligonuclcotide (solid line) are compared. 
a program provided by Jasco (Japan) using Yang's data as 
reference [16]. 
Fig. 4b shows the CD signal of an equimolar mixture of 
HDBD protein with la DNA site. The signal of free HDBD and 
that of the Ia-HDBD complex is similar, especially in the region 
between 205 nm and 250 nm (Fig. 4b), where the DNA signal 
is less intense than the protein signal. Thus, the spectrum of 
protein seems not to be drastically modified upon DNA bind- 
ing. This is consistent with the fact that the calculated content 
of cz-helix and fl-sheet of HDBD alone (see above), is rather 
comparable to the structure of the DNA binding domain of 
HNF-37 when complexed to DNA [4]. 
By contrast, significant signal change upon the complex for- 
mation can be observed around 280 nm and below 200 nm (Fig. 
4b). A positive lobe o fDNA CD at 280 nm becomes larger, and 
that at 190 nm becomes maller (compare Fig. 4a and 4b). Since 
CD signal of DNA is larger than that of protein in this region, 
the signal change is probably due to a conformational change 
of DNA upon interaction with the protein. 
4. Discussion 
The transferrin enhancer presents a modular organization 
maintained through DNA-protein and protein-protein ter- 
actions. This enhancer interacts with a liver-enriched transcrip- 
tion factor HNF-3c~ and ubiquitous proteins [10]. As a first step 
to understand this complex structure, it is important to study 
the interaction between each of the transcriptional factors and 
their corresponding specific DNA binding sites. Therefore, the 
purpose of this work was to study the interaction between 
HDBD, a fragment of 128 amino acid residues containing the 
DNA binding domain of HNF-3cz protein, and its Ia target site 
in the Tf enhancer. 
Previous work concerning the behaviour of different HNF- 
3/fkh proteins in the presence of their specific DNA binding 
sites have shown that subtle nucleotide alterations within and 
in the flanking regions of the DNA target core, generate diver- 
sity in the specificity of the protein recognition [6,7]. In addi- 
tion, indirect manifestations of these nucleotide alterations as 
DNA helicity and topology also seem to be important for the 
observed iversity [7]. In contrast, the amino acids involved in 
the DNA interaction, mainly those that make direct base con- 
tacts, are highly conserved in the fkh family. The question that 
may be addressed concerns the mechanisms by which these 
highly homologous proteins, binding to similar but different 
DNA sites, are able to specifically regulate their target genes. 
An interesting method to study protein DNA interactions i  
the recently developed BIAcore instrument that monitors ur- 
face plasmon resonance [17], permitting the real time observa- 
tion of binding phenomena. The binding kinetics of two differ- 
ent transcription factors were recently analyzed by this method 
[13,18], and the results proved to be consistent with other tech- 
niques such as EMSA and filter binding assays [19]. 
The results presented here have shown that HDBD interacts 
with a strong affinity (K d of about l0 s M) with a DNA frag- 
ment spanning the la specific binding site (Table 1 and 2). The 
affinity is reduced upon the modification of the sequence of the 
target DNA, as expected from our previous experiments (refs. 
[10,11], Fig. 1 and data not shown). As shown in Table 1. the 
association rate constant (ka~s) reveals a rapid binding phenom- 
enon. It is interesting to note that, in contrast o the kj~s~ con- 
stant, the k,,~ is somehow dependent on protein concentration. 
The comparison of the two methods employed to the k,~ deter- 
mination, namely linearized rate equations and non-linear anal- 
ysis (see section 2) suggest a dependence between protein con- 
centration and binding rate. Our suggestion to explain this 
phenomenon relies on the existence of a secondary' non-specific 
binding event that was indeed observed when the dissociation 
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part of the curves were further analyzed (Table 2). This hypoth- 
esis was recently analyzed in experiments performed with the 
ETS-1 and the lac repressor proteins [13,18]. 
The HDBD-DNA interaction has been further characterized 
with the help of CD and fluorescence spectroscopies. Our re- 
sults indicate that the protein fluorescence is quenched upon 
binding of HDBD to DNA (Fig. 3b). This suggest that one or 
more of the three tryptophan residues present in HDBD are 
affected by DNA binding. The titration of the protein by DNA 
shows that the fluorescence decreases linearly with increasing 
the DNA concentration, reaching a plateau at about one DNA 
fragment per protein molecule (Fig. 3c). This binding stoi- 
chiometry indicates that the protein binds to DNA in a monom- 
eric form. This was also observed with the DNA binding do- 
main of HNF-3y. In addition, size exclusion chromatography 
of the protein showed that HDBD, in the absence of DNA, is 
also in a monomeric form in solution (Fig. 3a). 
The spectroscopic analyses of the CD spectrum of HDBD 
(Fig. 4a) showed that the protein alone has a stable secondary 
structure in solution. An important observation i our work is 
that HDBD secondary structure seems not to be significantly 
modified upon DNA binding (Fig. 4b). There appears to be no 
induction or destabilization f an c~-helix. This contrasts with 
the case of bZIP proteins: an induction of an s-helix upon 
DNA binding was observed when bZIP proteins like Fos, Jun 
and GCN4 were analyzed [20,21]. 
Interestingly, CD measurements indicate a significant change 
in the structure of DNA (Fig. 4a and b). Since the CD signal 
depends upon different structural parameters of DNA [22], 
physical interpretation f the CD change observed here is diffi- 
cult. Nevertheless, the results suggest that the binding of 
HDBD alters DNA structure, and this can be one of the ways 
through which HNF-3~ influences transcription mechanisms. 
Indeed, as observed by X-ray crystallography, the interaction 
of HNF-37/ DNA binding domain with its transthyretin pro- 
moter binding site induces a 13 ° bend, narrowing the major 
groove in contact with the protein [4]. Interestingly, using a 
circular permutation assay, it was recently demonstrated that 
binding to their target sites of the FREAC proteins, induces a
bending of the DNA at an angle of 80-90 ° [7]. The differences 
observed when using the HNF-3y or the FREAC DNA binding 
domains may reflect a difference in binding characteristics of
the proteins or the result of the different experimental methods 
used. Nevertheless, our results and those of others strongly 
suggest that the generation ofmodifications of the DNA spatial 
organization upon binding with fkh proteins is a general prop- 
erty of these proteins, and may reflect a characteristic of their 
function as gene regulators. 
To analyze some of the data presented here, we took advan- 
tage of the fact that the crystal structure of HNF-3y DNA 
binding domain, although complexed to an imperfect HNF-3 
DNA site, was already available [4]. Indeed, the sequence iden- 
tity between the DNA binding domains of HNF-3~ and HNF- 
3)' is 95%. On the contrary, the DNA target sites are different. 
It is interesting topoint out that DNA sequences highly homol- 
ogous or identical to the Ia Tf site were presented as low- 
affinity binding sites for the HNF-3y DNA-binding domain 
[14]. The kinetic parameters presented inthis paper indicate, on 
the contrary, that the HNF-3c~ binding domain interacts with 
the Ia sequence with a high affinity (Table 1). It is clear that 
a more thorough analysis of the structure of fkh proteins with 
distinct DNA recognition specificity is necessary to understand 
how these similar proteins regulate the expression of different 
target genes. However, it is also evident hat, when technical 
limitations were overcome, these studies must be enlarged by 
using whole proteins instead of their isolated DNA binding 
domains. 
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